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Introduction
Major structural birth defects collectively affect 3 to 5% of
births in the United States and contribute substantially to
mortality and morbidity (CDC, 2008; TDSHS, 2015). Since
2000, the National Birth Defects Prevention Network
(NBDPN) has annually published state-specific data for
selected major birth defects affecting a range of organ sys-
tems, including central nervous, eye, ear, cardiovascular,
orofacial, gastrointestinal, genitourinary, and musculoskel-
etal, as well as chromosomal and other conditions, such as
amniotic bands. While the NBPDN list of birth defects had
remained relatively unchanged for two decades, it was
recently revised and released with the 2014 NBDPN
Annual Report (Mai et al., 2014). Several factors necessi-
tated an in-depth examination of the list of conditions: (1)
development of national data quality standards for birth
defects surveillance in the United States; (2) transition of
the diagnostic coding system from the International Classi-
fication of Diseases, 9th Revision, Clinical Modification
(ICD-9-CM) to ICD-10-CM; and (3) inclusion of newborn
screening for critical congenital heart defects (CCHD), with
12 primary and secondary CCHD targets, on the national
Recommended Uniform Screening Panel. The revision pro-
cess included a review of each condition in relation to its
public health importance, state of current knowledge, and
clinical factors, such as accuracy of diagnosis within a
child’s first year of life. Table 1 presents the revised list of
birth defects and their diagnostic codes [ICD-9-CM and
Centers for Disease Control and Prevention/British Pediat-
ric Association Classification of Diseases (CDC/BPA)].
The data component of the 2015 NBDPN Annual Report
comprises: (1) state-specific data from 41 population-based
birth defects surveillance programs for the 47 major birth
defects listed in Table 1; (2) a directory of state birth defects
surveillance programs, which details data collection, surveil-
lance methodology, and birth defects contacts; and (3) a
descriptive data brief further highlighting the variability in
prevalence estimates across population-based birth defects
programs.
State-Specific Data Collection and Presentation
of 47 Major Birth Defects
Starting in February 2015, the NBDPN Data Committee,
in collaboration with CDC, reviewed and refined the data
collection process. This included updating the data dic-
tionary and determining the focus of the data brief. A
call for data was then issued in April 2015 to
population-based birth defects surveillance programs in
the United States. Programs were asked to submit data
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TABLE 1. National Birth Defects Prevention Network (NBDPN) List of Reported
Birth Defects by Disease Classification Codes
Birth defects
Disease classification codes
International
Classification
of Diseases,
9th Revision,
Clinical Modification
(ICD-9-CM)
Centers for
Disease Control
and Prevention/British
Pediatric Association
Classification
of Diseases
(CDC/BPA)
Central nervous system
Anencephaly 740.0 – 740.1 740.00 – 740.10
Spina bifida without
anencephaly
741.0, 741.9
without
740.0 - 740.1
741.00 – 741.99
without
740.00 – 740.10
Encephalocele 742.0 742.00 – 742.09
Holoprosencephaly 742.2 742.26
Eye
Anophthalmia/
microphthalmia
743.0, 743.1 743.00 – 743.10
Congenital cataract 743.30 – 743.34 743.32
Ear
Anotia/microtia 744.01, 744.23 744.01, 744.21
Cardiovascular
Common truncus
(truncus arteriosus)
745.0 745.00
(excluding 745.01)
Transposition of the
great arteries (TGA)
745.10, .12, .19 745.10 – 745.12,
745.18 – 745.19
dextro-Transposition
of great arteries (d-
TGA) – for CCHD
screeninga
745.10 745.10, 745.11,745.19
Tetralogy of Fallot 745.2 745.20 – 745.21, 747.31
Ventricular septal
defect
745.4 745.40 – 745.49
(excluding 745.487,
745.498)
Atrial septal defect 745.5 745.51 – 745.59
Atrioventricular septal
defect (endocardial
cushion defect)
745.60, .61, .69 745.60 – 745.69, 745.487
Pulmonary valve
atresia and stenosis
746.01, 746.02 746.00, 746.01
Pulmonary valve atresia
– or CCHD
screeninga
746.01 746.00
TABLE 1. Continued
Birth defects
Disease classification codes
International
Classification
of Diseases,
9th Revision,
Clinical Modification
(ICD-9-CM)
Centers for
Disease Control
and Prevention/British
Pediatric Association
Classification
of Diseases
(CDC/BPA)
Tricuspid valve atresia
and stenosis
746.1 746.100, 746.106
(excluding 746.105)
Tricuspid valve
atresia– for CCHD
screeninga
746.1 746.100
Ebstein anomaly 746.2 746.20
Aortic valve stenosis 746.3 746.30
Hypoplastic left heart
syndrome
746.7 746.70
Coarctation of aorta 747.10 747.10 – 747.19
Total anomalous
pulmonary venous
connection
747.41 747.42
Single ventricle 745.3 745.3
Interrupted aortic arch 747.11 747.215 – 747.217
Double outlet right
ventricle
745.11 745.13 – 745.15
Orofacial
Cleft palate alone
(without cleft lip)
749.0 749.00 – 749.09
Cleft lip alone (without
cleft palate)
749.1 749.10 – 749.19
Cleft lip with cleft
palate
749.20-749.25 749.20 – 749.29
Choanal atresia 748.0 748.00
Gastrointestinal
Esophageal atresia/
tracheoesophageal
fistula
750.3 750.30 – 750.35
Rectal and large
intestinal atresia/
stenosis
751.2 751.20 – 751.24
Biliary atresia 751.61 751.65
Small intestinal atre-
sia/stenosis
751.1 751.10 – 751.19
BIRTH DEFECTS RESEARCH (PART A) 103:972–994 (2015) 973
using templates provided in Excel or SAS (SAS Institute,
Inc., Cary, NC). CDC performed data quality checks, and
state programs validated their data and approved final
data table presentation.
Participating birth defects surveillance programs sub-
mitted case counts of the reportable birth defects shown
in Table 1 and the number of live births occurring from
January 1, 2008 through December 31, 2012. These cases
were stratified by U.S. Census maternal racial/ethnic
groups: non-Hispanic white, non-Hispanic black, Hispanic,
non-Hispanic Asian/Pacific Islander, non-Hispanic Ameri-
can Indian/Alaska Native, and other/unknown. Addition-
ally, as maternal age is strongly associated with selected
trisomies and gastroschisis, case counts for these defects
were submitted stratified by maternal age at delivery in
six categories: less than 20 years, 20 to 24 years, 25 to 29
years, 30 to 34 years, 35 to 39 years, and 401 years.
STATE-SPECIFIC DATA PRESENTATION
State-specific data from 41 population-based birth defects
surveillance programs for 2008 to 2012 are shown elec-
tronically at Supporting Information. The data are presented
in two tables for each state program. The first table shows
birth defect counts and prevalence per 10,000 live births
by maternal racial/ethnic categories. The second table
presents counts and prevalence for trisomies and gastro-
schisis by two maternal age categories (less than 35 years,
351 years). The prevalence is calculated by dividing the
number of birth defect cases for any pregnancy outcome by
the total number of live births for the reported years and
then multiplying by 10,000 (Mason et al., 2005). The
denominator used to calculate the prevalence for all birth
defects is total live births except for hypospadias and
Turner syndrome, which are calculated using total male live
births and total female live births, respectively.
State-specific notes and clarifications about the data,
such as methodologic changes and inclusion of probable/
possible diagnoses, are included in the data tables. Addi-
tional information about each state program methodology
is available in the accompanying birth defects program
directory.
Descriptive Data Brief on Observed Variability in
Prevalence Estimates Across Population-Based
Birth Defects Programs
This descriptive data brief includes prevalence-based sum-
maries for birth defects listed in Table 1 from 38 of the 41
population-based birth defects surveillance programs con-
tributing data to this report (three programs were
excluded in the data brief due to their level of data aggre-
gation). State programs were grouped by their case-finding
approach (active or passive). The 15 programs in the
active case-finding category were: Arizona, Arkansas, Dela-
ware, Georgia (metropolitan Atlanta), Iowa, Louisiana,
Massachusetts, Minnesota, New Hampshire, North Carolina,
TABLE 1. Continued
Birth defects
Disease classification codes
International
Classification
of Diseases,
9th Revision,
Clinical Modification
(ICD-9-CM)
Centers for
Disease Control
and Prevention/British
Pediatric Association
Classification
of Diseases
(CDC/BPA)
Genitourinary
Renal agenesis/
hypoplasia
753.0 753.00 – 753.01
Bladder exstrophy 753.5 753.50
Hypospadias 752.61 752.60 – 752.62
(excluding 752.61
and 752.621)
Congenital posterior
urethral valves
753.6 753.60
Cloacal exstrophy 751.5 751.555
Musculoskeletal
Gastroschisis 756.73
(as of 10/1/09)
756.71
Omphalocele 756.72
(as of 10/1/09)
756.70
Diaphragmatic hernia 756.6 756.610 – 756.617
Limb deficiencies
(reduction defects)
755.2 – 755.4 755.20 – 755.49
Craniosynostosis No specific code 756.00 – 756.03
Clubfoot 754.51, 754.70 754.50, 754.73
(excluding 754.735)
Chromosomal
Trisomy 13 758.1 758.10 – 758.19
Trisomy 21
(Down syndrome)
758.0 758.00 – 758.09
Trisomy 18 758.2 758.20 – 758.29
Turner syndrome 758.6 758.60 – 758.69
Deletion 22q11.2 758.32 758.37
aThe primary targets for CCHD screening include seven conditions:
hypoplastic left heart syndrome, pulmonary atresia with intact sep-
tum, tetralogy of Fallot, total anomalous pulmonary venous connec-
tion, dextro-transposition of great arteries (d-TGA), tricuspid atresia,
and truncus arteriosus. The NBDPN traditionally monitors all TGA,
and both atresia and stenosis for pulmonary and tricuspid valve con-
ditions; however, for CCHD screening reporting purpose, these con-
ditions are also reported as d-TGA, pulmonary valve atresia, and
tricuspid valve atresia.
CCHD, critical congenital heart defect.
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Oklahoma, Puerto Rico, South Carolina, Texas, and Utah;
23 programs in the passive case-finding category were:
Colorado, Florida, Illinois, Indiana, Kansas, Kentucky, Maine,
Maryland, Michigan, Mississippi, Missouri, Nebraska, Nevada,
New Jersey, New Mexico, New York, Oregon, Rhode Island,
Tennessee, Vermont, Virginia, West Virginia, and Wisconsin.
The defects are displayed by organ system (Tables 2A:
central nervous; 2B: ear and eye; 2C: cardiovascular; 2D:
orofacial; 2E: gastrointestinal; 2F: genitourinary; 2G: muscu-
loskeletal; and 2H: chromosomal). Within each organ sys-
tem, the conditions are then presented, when possible, in
order by the magnitude of the distribution of the preva-
lence estimates submitted from the 38 birth defects surveil-
lance programs.
For each of the 47 defects, we present prevalence-based
summary statistics by case-finding approach (total, active,
passive) and by maternal race/ethnicity groups (white non-
Hispanic, black non-Hispanic, Hispanic, and all race/ethnic-
ity combined). Of note, for these analyses the state-specific
data are not pooled across state programs. The mean preva-
lence is calculated as the mean of the individual state preva-
lences, with each state weighted equally, regardless of
population size. We describe the range of state-specific
prevalence estimates by presenting the mean, Chebyshev
interval (mean6 two standard deviations) (Berenson et al.,
2012), median (P50), inter-decile interval [10th percentile
(P10), 90th percentile (P90)], and inter-quartile interval
[25th percentile (P25), 75th percentile (P75)]. The mean and
median describe the central tendency of the set of state-
specific prevalence estimates, and the intervals describe the
variation of the set of state-specific prevalence estimates.
Specifically, the Chebyshev interval, a useful metric for non-
normal distributions, captures at least 75% of its state-
specific prevalence estimates. Each inter-quartile interval
captures approximately 50% of the state-specific prevalence
estimates, and the inter-decile interval captures approxi-
mately 80% of the state-specific prevalence estimates.
While the inter-quartile interval is more familiar, the inter-
decile interval is a better companion to the Chebyshev inter-
val because they capture similar proportions of the state-
specific prevalence estimates; thus both interval measures
were included in the data tables. For example, 38 state pro-
grams contributed data for anencephaly with a mean preva-
lence estimate of 1.7 cases/10,000 live births (LB), with at
least 75% of these 38 program prevalence estimates
between 0.0 and 3.8 cases/10,000 LB (Chebyshev interval).
The overall median is 1.5 cases/10,000 LB, and approxi-
mately 80% of these 38 estimates are between 0.3 and 3.0
cases/10,000 LB (inter-decile percentile interval). With
respect to the inter-quartile percentile interval, approxi-
mately 50% of the 38 estimates are between 0.9 and 2.5
cases/10,000 LB.
The data tables include corresponding boxplots whose
vertical widths are weighted to correspond to the race/
ethnicity distribution of birth defects cases for non-
Hispanic white, non-Hispanic black, and Hispanic (dis-
played from top to bottom, respectively). Figure 1 details
the components of the boxplots.
Additional data presentations are included for trisomies
and gastroschisis by three maternal age categories (<25
years, 25–34 years, and 351 years) in Tables 3A and 3B,
respectively. These tables use the same descriptive meas-
ures for central tendency and dispersion as the maternal
race/ethnicity tables (i.e., mean, Chebyshev interval,
median, inter-decile interval, and inter-quartile interval).
SELECTED HIGHLIGHTS OF BIRTH DEFECTS-SPECIFIC VARIABILITY
Central nervous system defects (Table 2A). While the average
(mean or median) prevalence estimates of anencephaly
and spina bifida were highest among Hispanics across all
programs, more variability was observed for this group
compared with non-Hispanic whites and non-Hispanic
blacks. For anencephaly, the Chebyshev interval for His-
panics was 0.0 to 7.9 cases/10,000 LB while the interval
was 0.0 to 3.5 cases/10,000 LB for non-Hispanic whites
and 0.0 to 4.1 cases/10,000 for non-Hispanic blacks. Anen-
cephaly also exhibited higher overall prevalence and
greater variability among programs with active case-
finding compared with passive case-finding. In contrast,
the case-finding approach appeared to have little impact
on both average prevalence and variability of spina bifida.
Passive case-finding programs generally had higher
prevalence estimates than active case-finding programs for
holoprosencephaly, but the dispersion in these estimates
was much wider (Chebyshev interval 0.0–6.6 cases/10,000
LB) for the passive compared with active case-finding pro-
grams (0.3–2.5 cases/10,000 LB).
Eye and ear defects (Table 2B). The average prevalence and dis-
persion for the eye defects, anophthalmia/microphthalmia
and congenital cataract, were relatively similar across the
racial/ethnic groups (non-Hispanic whites, Hispanics, and
non-Hispanic blacks). However, the active-case finding pro-
grams reported somewhat higher average prevalence esti-
mates. Less dispersion in the prevalence estimates was
observed for anophthalmia/microphthalmia than for con-
genital cataract.
The state prevalence estimates for anotia/microtia
among Hispanics showed much more variability than other
race/ethnicity groups (Chebyshev interval 0.0–8.4 cases/
10,000 LB for Hispanics compared with 0.0–3.0 and 0.0–
3.6 cases/10,000 LB for non-Hispanic whites and non-
Hispanic blacks, respectively). While active case-finding
programs reported approximately 50% higher prevalence
estimates, this was accompanied by a wider dispersion
around the mean and median values.
Cardiovascular defects (Table 2C). The mean prevalence estimates
reported were highest among non-Hispanic blacks for sev-
eral cardiac conditions (interrupted aortic arch, atrioven-
tricular septal defect [AVSD], tetralogy of Fallot); however,
some of the higher observed differences were attenuated
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when examining the median values. For example, the prev-
alence estimate for interrupted aortic arch among non-
Hispanic blacks shifted from a mean of 0.8 cases/10,000
LB to a median of 0.5 cases/10,000 LB, which was closer
to the estimates for the other groups. Other birth defects
(e.g., single ventricle, tricuspid valve atresia and stenosis,
pulmonary valve atresia and stenosis) also seemed to have
higher mean prevalence estimates among non-Hispanic
blacks, but had wide overlapping inter-quartile ranges.
Higher average prevalence among non-Hispanic whites
was observed for aortic valve stenosis and coarctation of
the aorta, and higher average prevalence among Hispanics
for total anomalous pulmonary venous return.
Active case-finding programs reported relatively similar
or higher average prevalence estimates for most cardiac
conditions on the NBDPN birth defects list except for atrial
septal defect. The average prevalence estimates for this
condition were higher for passive case-finding programs,
and this was accompanied by wide dispersion. For exam-
ple, the Chebyshev interval for atrial septal defect was 0.0
to 204.6 cases/10,000 LB for passive case-finding pro-
grams compared with 0.0 to 74.4 cases/10,000 LB. A simi-
lar pattern did not emerge for ventricular septal defect.
For AVSD, active case-finding programs had substantially
higher average prevalence across all three racial/ethnic
groups than passive case-finding programs, with barely
any overlap in the inter-quartile ranges. However, the dis-
persion was similar between active and passive programs.
Orofacial defects (Table 2D). Little variation was observed in the
average prevalence for choanal atresia across case-finding
programs or racial/ethnic groups. Among clefts, non-
Hispanic blacks consistently showed the lowest average
prevalence for all types of orofacial clefts (cleft lip alone,
cleft lip with cleft palate, and cleft palate alone). The case-
finding approach did not appear to impact the average
prevalence of orofacial conditions or the spread of state
prevalence values.
Gastrointestinal defects (Table 2E). Even with relatively wide dis-
persions, the average prevalence estimates were similar
among racial/ethnic groups except among non-Hispanic
blacks. Among this group, slightly higher average preva-
lence for biliary atresia and lower average prevalence for
rectal and large intestinal atresia/stenosis, were noted.
While the prevalence estimates observed for the four
gastrointestinal defects on the NBDPN list were similar
across case-finding programs, the inter-quartile intervals
from active case-finding programs were narrower than
those of passive case-finding programs.
Genitourinary defects (Table 2F). Compared with non-Hispanic
whites and blacks, Hispanics had a higher prevalence of
bladder exstrophy and renal agenesis/hypoplasia (in the
active case-finding programs). However, the dispersion in
the prevalence estimates was relatively wide. In fact, for
the estimates for renal agenesis/hypoplasia amongTA
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Hispanics, the Chebyshev interval was five times higher
for active case-finding programs (0–36.3 cases/10,000 LB)
compared with passive case-finding programs (0–7.4
cases/10,000 LB). The average prevalence of congenital
posterior urethral valves was higher among non-Hispanic
blacks. Hispanics appeared to have a consistently lower
prevalence of hypospadias.
The reported average prevalence for hypospadias and
cloacal exstrophy were higher among states with passive
case-finding ascertainment, but much of this was driven
by a large dispersion. For example, the Chebyshev inter-
val for cloacal exstrophy was 16 times wider for passive
case-finding programs (0.0–8.3 cases/10,000 LB) com-
pared with active case-finding programs (0.0–0.5 cases/
10,000 LB).
Musculoskeletal defects (Table 2G). In general, average prevalence
was similar across race/ethnic groups with the exception of
omphalocele, which appeared to be higher among non-
Hispanic blacks. Active case-finding programs reported
higher average prevalence for clubfoot and omphalocele. For
clubfoot, active case-finding programs not only reported
higher prevalence estimates, but also less variability (mean
of 16.7 cases/10,000 LB and Chebyshev interval of 12.7–
20.8 cases/10,000 LB) compared with passive case-finding
programs (mean of 11.7 cases/10,000LB and Chebyshev
interval of 1.6–21.7 cases/10,000 LB).
As one of the new conditions added to the NBDPN list,
craniosynostosis was reported by only 15 programs for
this data brief. Active case-finding programs had much
higher prevalence estimates across all three racial/ethnic
groups, especially for non-Hispanic whites, with only a
slight overlap in the inter-quartile ranges. The variations
observed in the prevalence estimates appeared to be sensi-
tive to extreme values (wide dispersion observed using the
Chebyshev intervals but with tighter inter-quartile ranges).
Chromosomal conditions (Table 2H). Hispanics seemed to have
slightly higher average prevalence of trisomy 21; non-
Hispanic blacks seemed to have slightly higher average prev-
alence of trisomies 13 and 18. The variability in the race-
ethnicity specific estimates, however, is substantial, espe-
cially for trisomy 18, both between active and passive case-
finding programs and within the group of states conducting
active ascertainment. Active case-finding programs generally
reported higher average prevalence for chromosomal condi-
tions, but showed a wider inter-quartile dispersion except
for deletion 22 q11.2, where the range was extremely nar-
row (0.8–0.9 cases/10,000 LB).
Maternal age (Tables 3A and 3B). The prevalence estimates for
all three trisomy conditions were slightly higher among
active case-finding programs, with a pronounced jump in
prevalence estimates for older mothers (35 years), espe-
cially for Down syndrome. The variability in the preva-
lence estimates for trisomies 13 and 18 was markedlyTA
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larger among the programs with active case-finding than
programs with passive case-finding.
For gastroschisis, the average prevalence estimates were
highest among young mothers (<25 years), with the overall
magnitude of and variability in prevalence estimates rela-
tively consistent across surveillance case-finding approaches.
Discussion
Population-based birth defects surveillance systems in the
United States are generally established at the state level.
The NBDPN has published state-specific birth defects
counts and prevalence estimates for a range of major birth
defects for almost two decades, but has increasingly focused
its efforts on multi-state collaborative projects using pooled
data to characterize the prevalence and public health bur-
den, survival, and health outcomes of affected populations.
The expanded utility of state-based birth defects data war-
rants a closer examination of the variability behind preva-
lence estimates for specific birth defects across programs.
This report attempts to broadly describe variations
observed in birth defects data across 38 population-based
surveillance systems by examining two measures of central
tendency (mean and median) and the accompanying disper-
sion measures (standard deviations around the mean values
and inter-quartile and inter-decile intervals around median
values). Much of the variability observed can likely be
explained by (1) clinical practice and coding and (2) sur-
veillance ascertainment methodology.
CLINICAL PRACTICE AND CODING
Population-based birth defects surveillance data are largely
removed from direct medical care. Clinical practice and
patient access to health care can affect how information is
recorded in medical records. Prenatal care may be immedi-
ate, delayed, or absent which impacts the health of the
pregnancy and whether (and when) a birth defect is identi-
fied and recorded. After delivery, differences in the level of
hospital care, screening practices, and diagnostic capabilities
among birthing facilities could affect which birth defects are
detected and documented in medical records.
The quantity and quality of information ascertained
from medical records and how diagnostic case information
is coded can greatly affect the variations in prevalence
estimates observed for several birth defects. For example,
the wide dispersion observed in the average prevalence
estimates for atrial septal defects among passive case-
finding programs is likely driven by those programs’ reli-
ance on administrative datasets to ascertain cases using
an imprecise ICD-9-CM code that often times include other
conditions, such as patent foramen ovale.
Other issues such as diagnostic certainty of conditions, and
whether a program can definitively confirm cases, can affect
observed variations. Salemi et al. (2012) compared the passive
case ascertainment methodology used by the Florida Birth
Defects Registry with an enhanced system that used hospital
medical record review, and concluded that for epidemiologic or
clinical studies, the program should implement a more compre-
hensive case ascertainment strategy that includes case
confirmation.
SURVEILLANCE ASCERTAINMENT METHODOLOGY
Surveillance ascertainment methodology, specifically how pro-
grams find cases, which pregnancy outcomes are included,
and the type of data sources accessed, are critical drivers of
variability of prevalence estimates. Hobbs et al. (2001) noted
several potential sources of variability in case ascertainment
methods, data sources, case inclusion criteria, inclusion of
elective terminations and stillbirths, age limit, and diagnostic
confirmation and precision.
The ability of birth defects surveillance programs to
capture cases from all pregnancy outcomes is important,
but capturing this data can be challenging. Whereas most
systems capture both live births and fetal deaths, only
approximately 40% are able to capture terminations of
pregnancy (Mai et al., 2015). For some conditions, the lack
of other pregnancy outcomes can greatly affect data
FIGURE 1. Legend for the graphs in
the data tables.
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completeness. Cragan and Gilboa (2009) found that adding
prenatal sources from perinatologists’ offices to their data
sources increased the total defect prevalence by approxi-
mately 7% (28 per 1000 to 30 per 1000). The increase
was most pronounced for lethal conditions, such as anen-
cephaly. In general, active case-finding programs report
higher average prevalence estimates, but this is most likely
driven by inclusion of all pregnancy outcomes.
Wide variations can be observed for rare events within
a small population size. The occurrence of some individual
types of birth defects can be considered rare, and when the
counts are stratified further into subgroups, such as mater-
nal race/ethnicity, some extreme variations are observed.
For example, among active case-finding programs, the mean
prevalence estimate for tetralogy of Fallot among Hispanics
is almost twice the median prevalence estimate, due to
extreme right skewness (Chebyshev interval 0.0–33.2
cases/10,000 LB). This result is driven by one program that
ascertained a few cases from a small Hispanic LB popula-
tion (less than 1000 LB over a 5-year period).
Pooling data from multiple state programs for epidemio-
logic and etiologic studies assists in reducing certain
extreme-values challenges. Examples of studies using pooled
data include the NBDPN national estimates project and the
National Birth Defects Prevention Study. The NBDPN devel-
oped national estimates using pooled data from programs
that could confirm 100% of the cases (Canfield et al., 2006;
Parker et al., 2010). Likewise, the National Birth Defects Pre-
vention Study, one of the largest case-control studies to
examine risk factors for birth defects, used pooled birth
defects data from 10 population-based birth defects surveil-
lance programs that all followed a rigid study protocol for
case inclusion (Reefhuis et al., 2015; Dolk, 2015).
CONCLUSIONS
Given a lack of a national system for population-based birth
defects surveillance, multi-state data collaborations are impor-
tant to address the public health impact of birth defects in the
United States. As the utility of population-based birth defects
surveillance data increases with applications for policy deci-
sions, prevention efforts and the development of a research
agenda, understanding the variability behind prevalence esti-
mates for specific birth defects across states is key. True varia-
tion in occurrence is expected because populations have
different underlying risks; however our organizational experi-
ence has shown that some sources of variation are controllable.
The NBDPN released national standards for data quality in
2014 that included performance measures around complete-
ness, timeliness and accuracy of birth defects data (Anderka
et al., in press). Implementation of those standards across sur-
veillance systems will be an important step forward in control-
ling variability. Concerted efforts are needed to continue to
improve birth defects surveillance across population-based
programs.TA
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